pH Pharma signed a collaboration and licensing agreement for ADC development with Venn Therapeutics

pH Pharma, biotech, announced that collaboration and licensing agreement for ADC development made with Immunome, U.S. biotech 

(For more information, please refer to the link below)

http://www.biospectator.com/view/news_view.php?varAtcId=9127